Info

Celsense is a privately held biotechnology company offering novel MRI contrast agents that allow scientists and clinicians to monitor the position and quantity of transplanted cells non-invasively in vivo. The company's cell imaging products have application in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. Celsense is currently collaborating with leading pharmaceutical and biotechnology organizations to advance the development of cellular therapeutic applications and the study of inflammation. Celsense was founded in 2005 to commercialize imaging platforms developed at Carnegie Mellon University. Celsense currently offers products and methods used by scientists and clinicians in therapeutic discovery and preclinical research. The company is currently developing products suitable for human use.